Related Links
Current Releases
Stock Quote
Standard & Poor's
SEC Filings
Mailing List
Releases Archives
Opexa Therapeutics Headlines
11/05/2009 - 08:30 AM
Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009
11/04/2009 - 08:33 AM
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update
09/23/2009 - 08:00 AM
Opexa Triggers Milestone Payment Under Recently Announced Stem Cell Agreement
09/22/2009 - 08:00 AM
Opexa to Present at the Wall Street Analyst Forum 20th Annual Analyst Conference
09/08/2009 - 07:30 AM
Opexa to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009
09/08/2009 - 07:00 AM
Opexa Reports Additional Favorable Data with Tovaxin® for Multiple Sclerosis
08/13/2009 - 07:00 AM
Opexa Therapeutics Reports Second Quarter 2009 Financial Results and Corporate Update
08/10/2009 - 07:00 AM
Opexa Regains NASDAQ Compliance Following Stem Cell Agreement
08/09/2009 - 03:46 PM
Opexa gibt Vereinbarung mit führendem globalem Pharmaunternehmen zu Stammzellentechnologie bekannt
08/07/2009 - 07:00 AM
Opexa Announces Stem Cell Agreement with Leading Global Pharmaceutical Company
06/09/2009 - 07:30 AM
Opexa Therapeutics Receives Favorable NASDAQ Determination
05/15/2009 - 07:35 AM
Opexa Therapeutics Reports First Quarter 2009 Financial Results and Closes Private Financing
04/27/2009 - 07:00 AM
Opexa to Present Tovaxin® Data at the American Academy of Neurology 2009 Annual Meeting
04/24/2009 - 08:00 AM
Opexa Publication of Tovaxin® Clinical Data in Journal of Clinical Immunology
04/16/2009 - 07:30 AM
Opexa Therapeutics Reports Year End 2008 Financial Results
04/16/2009 - 07:30 AM
Opexa Therapeutics Closes First Tranche of Additional Financing
04/06/2009 - 07:00 AM
Opexa Therapeutics to Present at the Cambria Capital Investor Meeting
03/17/2009 - 07:30 AM
Opexa's Stem Cell Therapy for Diabetes Shows Progress
03/05/2009 - 07:30 AM
Opexa Provides Key Quality of Life Data on Tovaxin® for Multiple Sclerosis
01/20/2009 - 04:00 PM
Opexa Provides Update on Various Corporate Developments
11/04/2008 - 07:30 AM
Opexa to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
10/23/2008 - 08:00 AM
Opexa Therapeutics Reports Third Quarter 2008 Financial Results
10/23/2008 - 07:15 AM
Opexa Provides Additional Promising Data Including Statistically Significant Reduction in Disability With Tovaxin(R) for the Treatment of Multiple Sclerosis
10/20/2008 - 04:41 PM
Opexa to Host Third Quarter Financial Results and Corporate Update Conference Call on October 23, 2008
09/19/2008 - 02:55 PM
Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin(R) for the Treatment of Multiple Sclerosis
1
2
3
4
5
Next »
Releases Archives
